News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Urigen N.A. Engages Sichenzia Ross Friedman Ference LLP
December 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc. has engaged the law firm, Sichenzia Ross Friedman Ference LLP, to represent the Company in connection with its merger transaction with Valentis Inc. (NASDAQ: VLTS).
Twitter
LinkedIn
Facebook
Email
Print
Legal
Mergers & acquisitions
MORE ON THIS TOPIC
Insights
Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides
January 29, 2026
·
1 min read
·
Jennifer Smith-Parker
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
January 27, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Revolution Knows Its Worth as Merck Backs Off—For Now
January 26, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
January 26, 2026
·
1 min read
·
Tristan Manalac